Genentech, Inc.
Genentech, Inc. is listed as the manufacturer on 15 FDA drug label records covering 14 distinct active ingredients predominantly human prescription drug products.
About Genentech, Inc.
Genentech, Inc. is named as the labeler on 15 FDA drug label records. Its catalogue spans 14 distinct active ingredients, led by MOSUNETUZUMAB, ALECTINIB HYDROCHLORIDE, COBIMETINIB, FARICIMAB. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: adult patients, breast cancer, clinical studies, relapsed refractory, treatment adults, follicular lymphoma, years age, see dosage. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| MOSUNETUZUMAB | 2 |
| ALECTINIB HYDROCHLORIDE | 1 |
| COBIMETINIB | 1 |
| FARICIMAB | 1 |
| GLOFITAMAB | 1 |
| INAVOLISIB | 1 |
| MYCOPHENOLATE MOFETIL | 1 |
| OCRELIZUMAB | 1 |
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | INTRAVENOUS | 6 |
| — | — | ORAL | 5 |
| — | — | SUBCUTANEOUS | 3 |
| — | — | INTRAVITREAL | 1 |
| — | — | — | — |
| — | — | — | — |
FDA drug products from Genentech, Inc.
| Brand name | Generic | Type | Route |
|---|---|---|---|
| ALECENSA | ALECTINIB HYDROCHLORIDE | HUMAN PRESCRIPTION DRUG | ORAL |
| CellCept | MYCOPHENOLATE MOFETIL | HUMAN PRESCRIPTION DRUG | ORAL |
| Columvi | GLOFITAMAB | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| Cotellic | COBIMETINIB | HUMAN PRESCRIPTION DRUG | ORAL |
| Enspryng | SATRALIZUMAB | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
| Herceptin | TRASTUZUMAB | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| Itovebi | INAVOLISIB | HUMAN PRESCRIPTION DRUG | ORAL |
| Lunsumio | MOSUNETUZUMAB | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| Lunsumio Velo | MOSUNETUZUMAB | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
| OCREVUS | OCRELIZUMAB | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| PERJETA | PERTUZUMAB | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| POLIVY | POLATUZUMAB VEDOTIN | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| VABYSMO | FARICIMAB | HUMAN PRESCRIPTION DRUG | INTRAVITREAL |
| XOLAIR | OMALIZUMAB | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
| ZELBORAF | VEMURAFENIB | HUMAN PRESCRIPTION DRUG | ORAL |
Frequently asked questions
How many FDA drug products does Genentech, Inc. make?
15 FDA drug label records name Genentech, Inc. as the manufacturer, covering 14 distinct active ingredients.
What active ingredients does Genentech, Inc. produce?
The most frequent active ingredients in this portfolio are MOSUNETUZUMAB, ALECTINIB HYDROCHLORIDE, COBIMETINIB, FARICIMAB, GLOFITAMAB.
Are Genentech, Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.